Open AccessVivax Malaria Chemoprophylaxis: The Role of Atovaquone-Proguanil Compared to Other Options
Author(s) -
Eyal Meltzer,
Galia Rahav,
Eli Schwartz
Publication year - 2017
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/cix1077
Subject(s) - primaquine , proguanil , atovaquone , malaria , medicine , plasmodium vivax , mefloquine , chemoprophylaxis , malaria prophylaxis , plasmodium falciparum , pediatrics , immunology , chloroquine
Atovaquone-proguanil is considered causal prophylaxis (inhibition of liver-stage schizonts) for Plasmodium falciparum; however, its causal prophylactic efficacy for Plasmodium vivax is not known. Travelers returning to nonendemic areas provide a unique opportunity to study P. vivax prophylaxis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom